Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia

Sanne H. Tonino, Pablo J. van de Berg, Si La Yong, Ineke J. ten Berge, Marie José Kersten, René A. W. van Lier, Marinus H. van Oers, Arnon P. Kater

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)

Abstract

In patients with chronic lymphocytic leukemia (CLL), numbers of CD8 + CD45RA +/- CD27- effector T cells are expanded. We investigated whether this expansion is also present in other B cell malignancies and the possible mechanism underlying these changes. Whereas an increase in total CD4+ and CD8+ T cell numbers was found only in CLL, numbers of CD4+ and CD8+ effector T cells were significantly increased in both CLL and indolent lymphoma, but not aggressive lymphoma and myeloma. Interestingly, PD-1 expression was decreased on effector T cells and inversely correlated with effector T cell numbers, suggesting a functional role for PD-1 in regulating T cell homeostasis. In vitro experiments revealed impaired up-regulation of PD-1 upon T cell activation in the presence of malignant but also healthy B cells. Our data suggest that in CLL and indolent lymphoma, the malignant B cells affect PD-1 expression on effector T cells, resulting in an expansion of these subsets
Original languageEnglish
Pages (from-to)1785-1794
JournalLeukemia & lymphoma
Volume53
Issue number9
DOIs
Publication statusPublished - 2012

Cite this